Elite Trades From Anywhere

$100 Off Your First Year

00
Days
00
Hours
00
Mins
00
Sec
Claim Now
Jul 02, 8:32 PMNo clear catalyst identified for ALC's 4.25% gain on July 2, 2026
Index
-
Market Cap
33.95B
Enterprise Value
37.56B
Income
819.00M
Sales
10.63B
Book/sh
45.38
Cash/sh
3.40
Employees
25942
IPO
Apr 09, 2019
P/E
42.02
Forward P/E
17.53
PEG
1.28
P/S
3.19
P/B
1.54
P/C
20.47
P/FCF
19.64
EV/EBITDA
13.75
EV/Sales
3.53
Quick Ratio
1.39
Current Ratio
2.20
Debt/Eq
0.24
LT Debt/Eq
0.21
Option/Short
Yes / Yes
EPS (ttm)
1.66
EPS next Y
3.97
EPS next Q
0.76
EPS this Y
12.87%
EPS next Y
14.65%
EPS next 5Y
13.72%
EPS past 3/5Y
42.85% -
Sales past 3/5Y
6.06% 8.77%
EPS Y/Y TTM
-26.32%
Sales Y/Y TTM
7.14%
EPS Q/Q
-45.13%
Sales Q/Q
9.42%
Insider Own
1.23%
Insider Trans
0.00%
Inst Own
52.80%
Inst Trans
-2.29%
ROA
2.62%
ROE
3.71%
ROIC
3.06%
Gross Margin
55.36%
Oper. Margin
13.37%
Profit Margin
7.70%
SMA20
4.42%
SMA50
2.82%
SMA200
-7.78%
Trades
Shs Outstand
487.70M
Shs Float
481.40M
52W High
92.55 -24.73%
52W Low
61.83 12.65%
Volatility
1.94% 1.84%
ATR (14)
1.54
RSI (14)
60.35
Beta
0.87
Rel Volume
0.95
Avg Volume
2.01M
Volume
1,905,039
Perf Week
2.25%
Perf Month
8.37%
Perf Quarter
-7.75%
Perf Half Y
-12.17%
Perf YTD
-11.61%
Perf Year
-21.99%
Perf 3Y
-15.16%
Perf 5Y
-1.28%
Perf 10Y
-
Prev Close
66.82
Price
69.66
Change
4.25%
Date Action Analyst Rating Change Price Target Change
Feb-26-26Upgrade Wells Fargo Equal Weight → Overweight $97
Jan-30-26Initiated William Blair Mkt Perform
Jan-20-26Upgrade Deutsche Bank Hold → Buy
Jan-09-26Downgrade Stifel Buy → Hold
Dec-11-25Downgrade BofA Securities Buy → Underperform $75
Aug-21-25Downgrade JP Morgan Overweight → Neutral
May-20-25Downgrade Deutsche Bank Buy → Hold
May-14-25Reiterated BTIG Research Buy $102 → $99
Mar-28-25Reiterated Needham Buy $107 → $110
Mar-25-25Upgrade BofA Securities Neutral → Buy
May-20-26 03:33PM
May-06-26 08:30AM
05:32AM
May-05-26 04:30PM
Apr-30-26 04:30PM
08:02PM Loading…
Apr-14-26 08:02PM
Apr-09-26 12:01AM
Apr-07-26 12:15PM
Apr-06-26 08:03AM
Apr-02-26 04:30PM
Apr-01-26 08:30AM
Mar-17-26 09:33AM
08:12AM
06:57AM
Mar-16-26 04:57PM
09:34AM Loading…
Mar-10-26 09:34AM
Mar-07-26 06:50AM
Mar-05-26 09:31AM
Mar-04-26 08:30AM
Mar-03-26 07:02PM
Mar-02-26 09:40AM
08:03AM
Feb-27-26 12:43PM
09:40AM
Feb-26-26 09:42AM
08:00AM
Feb-25-26 02:32PM
02:01PM
09:45AM
08:30AM
07:50AM Loading…
07:50AM
Feb-24-26 10:30PM
04:30PM
Feb-23-26 07:00PM
Feb-22-26 07:47AM
Feb-19-26 09:15AM
Feb-18-26 05:18AM
Feb-17-26 09:55AM
08:03AM
Feb-03-26 05:23AM
Feb-02-26 08:57PM
09:02AM
Jan-30-26 01:00PM
09:54AM
Jan-23-26 04:35PM
Jan-20-26 04:30PM
Jan-16-26 09:32AM
05:00AM
Jan-15-26 01:06PM
Jan-07-26 07:38AM
Jan-06-26 08:00PM
12:32PM
12:14PM
09:52AM
06:13AM
Dec-30-25 04:30PM
Dec-19-25 03:51PM
12:59PM
11:45AM
Dec-17-25 06:47PM
04:53PM
01:17PM
10:55AM
07:20AM
Dec-16-25 03:58PM
01:32PM
09:12AM
07:00AM
Dec-15-25 06:35PM
Dec-12-25 05:29PM
08:40AM
Dec-11-25 08:06PM
02:19PM
09:47AM
09:39AM
09:17AM
09:17AM
07:00AM
Dec-10-25 01:34PM
07:05AM
Dec-09-25 02:25PM
12:39PM
08:30AM
Dec-08-25 01:28PM
08:16AM
08:00AM
Dec-03-25 12:02PM
Dec-02-25 04:14PM
Nov-13-25 09:21AM
Nov-12-25 02:35PM
02:02PM
01:19PM
07:13AM
04:26AM
Nov-11-25 06:30PM
04:30PM
Nov-10-25 07:00PM
08:00AM
Nov-07-25 12:51PM
10:10AM
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland.
CEO & DirectorMr. David J. Endicott
Senior VP & CFOMr. Timothy C. Stonesifer
Senior VP & COOMr. Ian Bell
Chief Accounting OfficerMargaret Buckley
SVP of Global Research & Development and Chief Scientific OfficerDr. Franck Leveiller Ph.D.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Duplan SergioOfficerFeb 26 '26Proposed Sale86.5415,0001,298,128Feb 26 03:55 PM
Attias LaurentOfficerFeb 26 '26Proposed Sale86.912,412209,634Feb 26 11:22 AM